Chargement en cours...
Development of orphan vaccines: an industry perspective.
The development of vaccines against rare emerging infectious diseases is hampered by many disincentives. In the face of growing in-house expenditures associated with research and development projects in a complex legal and regulatory environment, most pharmaceutical companies prioritize their projec...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Centers for Disease Control and Prevention
1999
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2640802/ https://ncbi.nlm.nih.gov/pubmed/10603207 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|